Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Karp

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 13, 2015
Can immunological principles and cross-disciplinary science illuminate the path to vaccines for HIV and other global health challenges?Christopher B Wilson, Christopher L Karp
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2007
Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogensChristopher L Karp, Paul G Auwaerter
The Journal of Experimental Medicine|March 14, 2012
Non-canonical alternatives: what a macrophage is 4Christopher L Karp, Peter J Murray
Molecular Metabolism|September 12, 2013
Obesity and the gut microbiome: Striving for causalityIsaac T W Harley, Christopher L Karp
Annals of the New York Academy of Sciences|June 26, 2002
Immunological barriers (opportunities?) to the use of bioengineered tissue: taking note of the innate immune systemChristopher L Karp, Richard Wenstrup, David L Butler
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Flt3 ligand treatment reverses endotoxin tolerance-related immunoparalysisMaria Wysocka, Luis J Montaner, Christopher L Karp
Nature Biotechnology|April 9, 2009
Getting to the core of the gut microbiomeMatthias H Tschöp, Philip Hugenholtz, Christopher L Karp
Nature Immunology|October 31, 2003
I-Tim-izing the pathways of counter-regulationMarsha Wills-Karp, Yasmine Belkaid, Christopher L Karp
Annals of Neurology|February 9, 2002
Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 productionAdriana A Byrnes, Justin C McArthur, Christopher L Karp
Immunological Reviews|February 24, 2015
Tuberculosis vaccines: barriers and prospects on the quest for a transformative toolChristopher L Karp, Christopher B Wilson, Lynda M Stuart
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 13, 2015
Can immunological principles and cross-disciplinary science illuminate the path to vaccines for HIV and other global health challenges?Christopher B Wilson, Christopher L Karp
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2007
Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogensChristopher L Karp, Paul G Auwaerter
The Journal of Experimental Medicine|March 14, 2012
Non-canonical alternatives: what a macrophage is 4Christopher L Karp, Peter J Murray
Molecular Metabolism|September 12, 2013
Obesity and the gut microbiome: Striving for causalityIsaac T W Harley, Christopher L Karp
Annals of the New York Academy of Sciences|June 26, 2002
Immunological barriers (opportunities?) to the use of bioengineered tissue: taking note of the innate immune systemChristopher L Karp, Richard Wenstrup, David L Butler
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Flt3 ligand treatment reverses endotoxin tolerance-related immunoparalysisMaria Wysocka, Luis J Montaner, Christopher L Karp
Nature Biotechnology|April 9, 2009
Getting to the core of the gut microbiomeMatthias H Tschöp, Philip Hugenholtz, Christopher L Karp
Nature Immunology|October 31, 2003
I-Tim-izing the pathways of counter-regulationMarsha Wills-Karp, Yasmine Belkaid, Christopher L Karp
Annals of Neurology|February 9, 2002
Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 productionAdriana A Byrnes, Justin C McArthur, Christopher L Karp
Immunological Reviews|February 24, 2015
Tuberculosis vaccines: barriers and prospects on the quest for a transformative toolChristopher L Karp, Christopher B Wilson, Lynda M Stuart
Pageof 9